Abstract
Background
To date, conflicting results have been reported about the association between metabolic syndrome (MetS) and periodonttitis.
Methods
Two hundred and eighty patients with type 2 diabetes were recruited from outpatients visiting diabetes clinics in Islamic Hospital, Amman-Jordan. The oral hygiene and the periodontal status of all teeth, excluding third molars, were assessed using the plaque index of Silness and Löe, the gingival index of Löe and Silness, probing pocket depth (PPD), and clinical attachment level (CAL). Data were analyzed using the general linear model multivariate procedure with average PPD, average CAL, percent of teeth with CAL ≥3 mm, and percent of teeth with PPD ≥3 mm as outcome variables and diabetes, MetS and its individual components as predictors.
Results
Overall, 83.2 % of patients with diabetes had MetS. In the multivariate analysis, patients with MetS had a significantly more severe periodontitis, as measured by average PPD and average CAL (P < 0.005). The extent of periodontitis, as measured by the percent of teeth with CAL ≥3 mm and the percent of teeth with PPD ≥3 mm, was also significantly greater among patients with MetS (P < 0.005). As the number of metabolic components additional to diabetes increased, the odds of having periodontitis increased, and the odds were greatest when all the components additional to diabetes were present (OR = 10.77, 95 % CI: 2.23 -51.95).
Conclusion
Patients with MetS displayed more severe and extensive periodontitis. Having other MetS components additional to diabetes increased the odds of having periodontitis.
Keywords: Periodontitis, Diabetes, Metabolic syndrome
Introduction
Metabolic syndrome (MetS) is a complex collection of components that are thought to arise from a visceral fat-type obesity involving hypertension and abnormal glucose and lipid metabolism [1]. The prevalence of MetS increases with age and varies with ethnicity and race [2]. The prevalence of MetS among adults in USA is 22.9 % [3], which is comparable to its prevalence among Canadian adult population (19.1 %) [4]. Higher MetS prevalence rates have been observed in the Eastern Mediterranean countries and Arab populations [5–9]. In Jordan, the prevalence of MetS among adults was alarmingly high (36.6 %) [10]. Lower prevalence of MetS has been found among European adults [11].
Periodontal disease is a group of infectious diseases triggered by periodontopathogens [12]. It is considered the most common chronic infection worldwide and in the US [13, 14]. Periodontitis and MetS are multi-factorial diseases sharing a common inflammatory pathway. Many people with MetS have a low grade systemic inflammation which is reported by elevated levels of inflammatory mediators such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrotic factor- α (TNF-α). Moreover, people who have periodontitis, which is a chronic inflammation, also have elevated levels of inflammatory markers (CRP, IL-6 and TNF-α) [15, 16]. There is growing evidence suggesting an association between periodontal disease and MetS components since positive correlation between obesity, hypertension, hyperglycemia and hyperlipidemia with periodontal disease has been reported [17, 18]. MetS has been shown to be associated with the prevalence, extent and severity of periodontal disease [15, 19–21] and a recent systematic review concluded that subjects affected by MetS are nearly twice more likely to have periodontitis than the rest of the population [22]. Furthermore, periodontal disease has effects on the glycemic control [23] and lipid metabolism [24].
This study is built on the concept that the three diseases (MetS, periodontal disease and diabetes mellitus) share common pathogenesis. The aim of this study was to assess the association between MetS and periodontal disease among patients with type 2 diabetes in Jordan.
Methods
Study population and sampling
The study was approved by the University Ethical Committee at Jordan University of Science and Technology. The participants were recruited from outpatients visiting the diabetes clinics in Islamic Hospital Amman-Jordan, over a period of six months between June-November 2011. All participants were interviewed and examined after they signed a written consent form. Patients were selected using systematic random sampling technique by choosing every third patient (i.e. patients registered with numbers such as 3, 6, 9, 12…) attending the clinics. About half of the interviewed patients met the inclusion criteria. Patients with a history of a systemic condition or medication use that might influence the severity of periodontitis were excluded (i.e. patients with a history of thyroid diseases, chronic renal problems and connective tissue diseases). Pregnant women and patients who were edentulous and those who had undergone periodontal treatment within the preceding 6 months were also excluded.
The power of this study to detect the association between MetS and periodontal disease given our sample size was calculated. To detect a minimal odds ratio of 3 at alpha level of 5 % in a sample that included 233 patients with MetS and assuming that 14 % of patients without MetS had periodontal disease, the power was calculated as 99 %. The power calculations were performed using Sample size online calculator (http://sampsize.sourceforge.net/iface/s3.html).
Data collection
Data were collected by a questionnaire answered by patients through personal interview and clinical examination. The questionnaire included questions about socio-demographic variables, medical history, smoking history, previous dental history, oral hygiene practice and clinical findings associated with periodontal examination. Participants were assured of the confidentiality of all obtained information and that collected data will only be used for scientific purposes.
Diabetes mellitus
Only patients with type 2 diabetes were included in this study. Patients were diagnosed with diabetes mellitus if they had fasting plasma glucose (FPG) ≥ 100 mg/dl or if they were taking medications for type 2 diabetes mellitus. Control of diabetes mellitus was investigated through glycated hemoglobin test (HbA1c). The FPG and HbA1c values were taken from recent tests included in patients’ files.
Hypertension
Hypertension was defined as systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, or under treatment of previously diagnosed hypertension as reported in patients’ medical records. Blood pressure was measured by a qualified nurse using a mercury sphygmomanometer on the same day of periodontal examination.
Hyperlipidemia
The diagnosis of hyperlipidemia was made by an endocrinologist based on the measurements of triglycerides (TG) and high density lipoproteins (HDL): TG ≥ 150 mg/dl and/or (HDL cholesterol level < 40 mg/dl in males and < 50 mg/dl in females), or if the patient was currently on specific treatment for lipid abnormalities.
Obesity
The participants were diagnosed as obese by measuring the waist circumference (WC), using a circumference measuring tape. The readings were rounded to the nearest centimeter. The diagnosis was made if the waist circumference was ≥ 94 cm for men and ≥ 80 cm for women. The weight was measured using a mechanical flat scale to the nearest kilogram, and height was measured to the nearest centimeter using a measuring rod. All these measurement were taken at the same day of examination, with the participants wearing light clothing and no shoes.
MetS definition
MetS was defined according to the International Diabetes Federation (IDF) definition [25]. According to the IDF definition, a person was defined as having MeS if he or she had central obesity (defined as waist circumference ≥94 cm for men and ≥80 cm for women, with ethnicity specific values for other groups) plus any two of the following four factors: 1) Raised TG level: ≥150 mg/dL (1.7 mmol/L), or specific treatment for this lipid abnormality, 2) Reduced HDL cholesterol: <40 mg/dL (1.03 mmol/L) in males and <50 mg/dL (1.29 mmol/L) in females, or specific treatment for this lipid abnormality, 3) Raised blood pressure: systolic BP ≥130 or diastolic BP ≥85 mm Hg, or treatment of previously diagnosed hypertension, 4) Raised fasting plasma glucose (FPG) ≥100 mg/dL (5.6 mmol/L), or previously diagnosed type 2 diabetes.
Periodontal clinical examination
The oral hygiene and the periodontal status of all teeth, excluding third molars, were assessed using, plaque index (PI) of Silness & Löe (1964) [26], probing pocket depth (PPD), and clinical attachment loss (CAL). Sterile dental mirrors and explorers were used to assess plaque accumulation and gingival status. Hu-Friedy periodontal probes with Williams’s markings (Diatech, Switzerland) were used to measure PPD and CAL. All teeth (excluding third molars), and six surfaces of each studied tooth (mesio-facial, mid-facial, disto-facial, mesio-lingual, mid-lingual, and disto-lingual) were assessed and scored for PI, GI, PPD and CAL. Plaque index was scored as follows: 0 = no plaque/debris 1 = A film of plaque adhering to the free gingival margin and adjacent area of the tooth. 2 = Moderate accumulation of soft deposit s within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye. 3 = Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin. The highest score of each reading was taken into consideration. Data were recorded on periodontal examination form.
Disease extent was defined by the percentage of deep pockets. The mean of the deepest reading for PPD and CAL was calculated within each mouth by dividing the value of deepest pockets on the total number of deep pockets. Periodontitis was defined as presence of four or more teeth with highest reading of PPD ≥ 3 mm and CAL ≥ 3 mm [27].
Reliability of questionnaire and periodontal examination
Clinical examinations were performed by one skilled examiner (RA). Before the beginning of the study, the measurement reliability was determined on the basis of examinations performed on 10 patients with severe periodontitis. Of the replications, 98 % were within 1 mm for PDs, and 97 % were within 1 mm for CALs.
Data management and analysis
The Statistical Package for Social Sciences software (SPSS Inc., version 15, Chicago, IL, USA) was used for data processing and data analysis. Characteristics of subjects’ variables were described using frequency distribution for categorical variables and mean and standard deviation for continuous variables. The Chi2 test was used to assess the association between categorical variables.
The multivariate analysis of the association between different disease status and periodontal parameters (average PPD, average CAL) and percentage of teeth with (PPD ≥3 mm, PPD ≥4 mm, PPD ≥5 mm, PPD ≥6 mm, CAL ≥3 mm, CAL ≥4 mm, CAL ≥5 mm and CAL ≥6 mm) was conducted using the General Linear Model procedure. Multivariate binary logistic regression was conducted to determine the association between each disease group (i.e. group of patients with MetS and group of patients with diabetes) and the prevalence of periodontal disease after adjusting for important variables. All variables that were significantly associated with periodontal disease constituted the best regression model. The association between obesity, hypertension, and hyperlipidemia, with diabetes and periodontal disease was tested, in separate models, for each disease group after adding that indicator to the best model. The association between diabetes, the increasing number of MetS components and periodontal disease was tested too. The statistical significance of the two-way interactions between independent variables was assessed with the use of forward stepwise regression.
The two-way interaction terms, one at a time, were added in the model containing all the main effects and were assessed for their significance using the likelihood ratio test. Crude odds ratios (ORs) and their 95 % confidence interval (CI) were calculated. A p-value of <0.05 was considered statistically significant.
Results
This study included a total of 280 patients with type 2 diabetes mellitus. Overall, 83.2 % of patients with diabetes had MetS. The patients aged between 21 and 80 years with a mean (±SD) age of 53.8 (±9.6) years. Socio-demographic, dental, anthropometric, clinical, and relevant characteristics of the participants are shown in Tables 1 and 2. About half (50.7 %) of patients were males and 49.3 % were females. About one third of patients (32 %) had university level education. Almost 30 % of patients reported brushing their teeth twice daily. Nearly half (51.8 %) of patients had duration of diabetes of ≤ 5 years, 28 % were taking insulin therapy, and 93.2 % were on oral hypoglycemic medications. Only 21.8 % of patients were well controlled (HbA1c ≤6.5 %). The majority (87.5 %) of the participants were obese, 87.1 % had elevated blood pressure, 65 % had increased triglycerides level (≥150 mg/dl), and 46.1 % had low HDL level.
Table 1.
Socio-demographic, dental and relevant characteristics of 280 patients with type 2 diabetes
| Variable | n (%) |
|---|---|
| Gender: | |
| Male | 142 (50.7) |
| Female | 138 (49.3) |
| Age (years): | |
| ≤45 | 56 (20.0) |
| 46–55 | 107 (38.2) |
| >55 | 117 (41.8) |
| Family income (JD): | |
| ≤500 JD | 168 (60) |
| >500 | 112 (40) |
| Education: | |
| Elementary | 107 (38.2) |
| Secondary | 86 (30.7) |
| University | 87 (31.1) |
| Residency area: | |
| Urban | 271 (96.8) |
| Rural | 9 (3.2) |
| Smoking: | |
| Non-smoker | 185 (66.1) |
| X-smoker | 34 (12.1) |
| Smoker | 61 (21.8) |
| Teeth brushing: | |
| Infrequent | 87 (31.1) |
| Once/day | 109 (38.9) |
| Twice/day | 84 (30.0) |
| Having fixed prosthesis | 186 (66.4) |
| Number of missing teeth: | |
| 0 | 53 (18.7) |
| 1–7 | 120 (43.0) |
| 8–18 | 107 (40.3) |
| Periodontitis | 111 (39.6) |
Table 2.
Anthropometric, clinical and relevant characteristics of 280 patients with type 2 diabetes
| Variables | n (%) |
|---|---|
| Diabetes duration (years): | |
| ≤5 | 145 (51.8) |
| >5 | 135 (48.2) |
| HbA1c (%): | |
| ≤6.5 | 61 (21.8) |
| >6.5 | 219 (78.2) |
| Diabetes treatment: | |
| On insulin | 78 (27.9) |
| On oral hypoglycemic drugs | 261 (93.2) |
| Increased Waist circumference | 245 (87.5) |
| Elevated blood pressure | 244 (87.1) |
| Increased triglycerides level | 182 (65) |
| Low HDL | 129 (46.1) |
| Metabolic syndrome (MetS) | 233 (83.2) |
Table 3 illustrates the extent and severity of periodontal disease according to MetS after adjusting for average PI, age, family income, residency area, smoking, teeth brushing and number of missing teeth. Patients with MetS had a significantly higher mean PPD (P < 0.005) and CAL (P = 0.001). The extent of periodontal disease was also significantly higher in patients with MetS as measured by average percent of teeth with the deepest CAL ≥3 mm (P < 0.005), CAL ≥4 mm (P < 0.005), and CAL ≥5 mm (P < 0.005).
Table 3.
Extent and severity of periodontal disease according to metabolic syndrome (MetS) among 280 patients with type 2 diabetes
| Variable | Metabolic syndrome | P-value* | |
|---|---|---|---|
| No (n = 47) | Yes (n = 233) | ||
| Mean (SD) | Mean (SD) | ||
| Average Probing Pocket Depth (PPD) | 1.29 (0.32) | 1.77 (0.42) | <0.005 |
| Average Clinical Attachment Level (CAL) | 1.52 (1.34) | 2.86 (1.59) | 0.001 |
| Average percent of teeth with deepest: | |||
| PPD ≥ 3 | 1.00 (2.83) | 11.08 (21.89) | 0.038 |
| PPD ≥ 4 | 0.33 (1.36) | 7.03 (20.77) | 0.159 |
| PPD ≥ 5 | 0.0 (0.0) | 5.24 (20.43) | 0.297 |
| PPD ≥ 6 | 0.0 (0.0) | 4.40 (20.30) | 0.392 |
| Average percent of teeth with deepest: | |||
| CAL ≥ 3 | 13.25 (23.24) | 54.54 (28.13) | <0.005 |
| CAL ≥ 4 | 10.44 (17.79) | 40.13 (30.05) | <0.005 |
| CAL ≥ 5 | 3.02 (6.93) | 24.03 (24.75) | <0.005 |
| CAL ≥ 6 | 1.89 (5.09) | 14.99 (22.76) | 0.160 |
*Adjusted for average PI, age, family income, residency area, smoking, teeth brushing, and number of missing teeth
Table 4 demonstrates the extent and severity of periodontal disease according to the number of metabolic abnormalities in the multivariate analysis. As the number of metabolic abnormalities in addition to diabetes increased; the severity of periodontal disease, as measured by average PPD and average CAL, significantly increased. The increasing number of components of MetS was significantly associated with higher extent of periodontal disease as measured by the average percent of teeth with CAL ≥3 mm, ≥4 mm, ≥5 mm, and ≥6 mm.
Table 4.
Extent and severity of periodontal disease according to the number of metabolic syndrome (MetS) components among 280 patients with type 2 diabetes
| The number of MetS components additional to diabetes mellitus | |||||
|---|---|---|---|---|---|
| One component n = 31 Mean (SD) | Two components n = 52 Mean (SD) | Three components n = 115 Mean (SD) | Four components n = 82 Mean (SD) | P-value* | |
| Average Pocket Probing Depth (PPD) | 1.25 (0.33) | 1.71 (0.33) | 1.7 (0.43) | 1.85 (0.46) | <0.005 |
| Average Clinical Attachment Level (CAL) | 1.11 (1.22) | 2.33 (1.3) | 2.85 (1.6) | 3.1 (1.65) | <0.005 |
| Average percent of teeth with deepest: | |||||
| PPD ≥ 3 | 0.91 (2.61) | 6.58 (10.67) | 10.40 (23.01) | 12.95 (23.64) | 0.459 |
| PPD ≥ 4 | 0.38 (1.53) | 1.82 (5.17) | 7.21 (22.43) | 8.76 (22.36) | 0.345 |
| PPD ≥ 5 | 0.0 (0.0) | 0.74 (18.77) | 6.03 (22.31) | 5.98 (21.77) | 0.437 |
| PPD ≥ 6 | 0.0 (0.0) | 0.07 (0.5) | 5.32 (22.32) | 5.00 (21.66) | 0.433 |
| Average percent of teeth with deepest: | |||||
| CAL ≥ 3 | 9.82 (15.73) | 39.54 (28.22) | 52.94 (29.46) | 59.5 (28.45) | <0.005 |
| CAL ≥ 4 | 6.95 (13.07) | 27.27 (27.04) | 39.01 (28.72) | 45.34 (32.2) | <0.005 |
| CAL ≥ 5 | 2.77 (7.54) | 16.32 (20.83) | 21.66 (24.11) | 28.22 (26.23) | 0.005 |
| CAL ≥ 6 | 1.04 (3.34) | 6.99 (9.93) | 13.08 (20.61) | 20.48 (27.99) | 0.004 |
*Adjusted for average PI, age, family income, residency area, smoking, teeth brushing, and number of missing teeth
The prevalence of periodontal disease according to MetS and its components is shown in Table 5. The prevalence of periodontal disease was higher among those who had MetS compared to those who did not have MetS (44.6 % vs. 14.9 %). The prevalence of periodontal disease in patients with diabetes was significantly increased as the number of metabolic components increased (P < 0.005). Diabetes mellitus was associated with significantly higher prevalence of periodontal disease when accompanied with increased waist circumference (P = 0.011), increased triglycerides (P = 0.005), and decreased HDL (P = 0.001), but not when accompanied with hypertension (P = 0.119).
Table 5.
Prevalence of periodontal disease among 280 patients with diabetes mellitus according to metabolic syndrome (MetS) and its components
| Periodontitis | p-value | ||
|---|---|---|---|
| Non (%) | Yesn (%) | ||
| Metabolic syndrome (MetS) | <0.005 | ||
| No | 40 (85.1) | 7 (14.9) | |
| Yes | 129 (55.4) | 104 (44.6) | |
| Number of metabolic components additional to diabetes mellitus | |||
| 1 component | 29 (93.5) | 2 (6.5) | <0.005 |
| 2 components | 32 (61.5) | 20 (38.5) | <0.005 |
| 3 components | 72 (62.6) | 43 (37.4) | <0.005 |
| 4 components | 36 (43.9) | 46 (56.1) | <0.005 |
| Waist circumference | 0.011 | ||
| Normal | 28 (80) | 7 (20) | |
| Increased | 141 (57.6) | 104 (42.4) | |
| Blood pressure | 0.119 | ||
| Normal | 26 (72.2) | 10 (27.8) | |
| Elevated blood pressure | 143 (58.6) | 101 (41.4) | |
| Triglycerides | 0.005 | ||
| Normal | 70 (71.4) | 28 (28.6) | |
| Increased | 99 (54.4) | 83 (45.6) | |
| HDL | 0.001 | ||
| Normal | 105 (69.5) | 46 (30.5) | |
| Low | 64 (49.6) | 65 (50.4) | |
Model I in Table 6 shows that patients with MetS were almost 3 times (OR = 3.28, 95 % CI: 1.3-8.3) more likely to have periodontal disease compared to patients without MetS. In model II, patients with diabetes were about 6 times (OR = 5.73, 95 % CI: 1.15-28.59) more likely to have periodontal disease if they had two more components of MetS compared to those who had one additional component only. Patients who had all the other components of metabolic syndrome had much higher odds of having periodontal disease (OR = 10.77, 95 % CI: 2.23-51.95) compared to those who had one additional component only. In model III, of the individual components of MetS, only HDL level was significantly associated with increased odds of having periodontal disease (OR = 1.99, 95 % CI: 1.15-3.46).
Table 6.
Multivariate analysis of association between metabolic syndrome (MetS) and its components with periodontal disease in separate models among 280 patients with diabetes mellitus
| Odds ratio (95 % confidence interval) of having periodontitis | p-value* | |
|---|---|---|
| Model I | ||
| Metabolic syndrome (MetS) | ||
| No | 1 | |
| Yes | 3.28 (1.30, 8.30) | 0.012 |
| Model II: Number of MetS additional to diabetes | ||
| 1 component | 1 | |
| 2 components | 5.73 (1.15, 28.59) | 0.03 |
| 3 components | 4.82 (1.03, 22.65) | 0.046 |
| 4 components | 10.77 (2.23, 51.95) | 0.003 |
| Model III: Individual components of MetS | ||
| Waist circumference | ||
| Normal | 1 | |
| Increased | 1.74 (0.63, 4.79) | 0.286 |
| Blood pressure | ||
| Normal | 1 | |
| Elevated | 1.12 (0.43, 2.90) | 0.812 |
| Triglycerides | ||
| Normal | 1 | |
| Increased | 1.41 (0.77, 2.60) | 0.268 |
| HDL | ||
| Normal | 1 | |
| Low | 1.99 (1.15, 3.46) | 0.004 |
*In the three models, the associations between periodontal disease and metabolic syndrome, individual components, and their combinations were adjusted for average PI, age, family income, residency area, smoking, teeth brushing, and number of missing teeth
Discussion
This study showed a positive association between periodontitis and MetS. Periodontitis was more common and severe in diabetic patients with MetS in Jordan compared to patients with no MetS. As the number of metabolic components additional to diabetes increased the severity and extent of periodontal disease increased.
Our study is the first in the Middle East that explores the association between MetS and periodontal disease among patients with diabetes. Other studies compared periodontal disease between patients with MetS and patients without MetS only without investigating the effect of individual components of MetS.
The findings of this study are consistent with the study conducted by Khader et al. (2008) [19] in Jordan and are in support of other studies‘ findings [20, 21]. Shimazaki et al. (2007) [28] reported that MetS is associated with increased risk of periodontal disease among Japanese women. On the other hand, Morita et al. (2010) [16] concluded that presence of periodontal pockets was associated with a positive conversion of MetS components, suggesting that preventing periodontal disease may prevent MetS. These studies may propose a two way relationship. However, longitudinal and interventional studies should be performed to investigate such a relationship.
In this study when each component additional to diabetes was analyzed separately, increased waist circumference (WC) and low HDL level were associated with significantly higher extent and severity of periodontal disease. Increased triglycerides (TG) level was associated with significant increase in the extent but not severity of periodontal disease, while hypertension was not significantly associated with either extent or severity of periodontal disease. This was comparable with the results reported by Shimazaki et al. (2007) [28], as increased WC, low HDL and fasting blood sugar had significant relationships with periodontal disease.
In contrast, Kushiyama et al. (2009) [20] reported that of the five MetS components, only high blood pressure and low HDL were each significantly associated with deep probing depths.
When the extent and severity of periodontal disease were analyzed according to the number of MetS components in multivariate analysis, the number of components additional to diabetes increased was associated with increased extent and severity of periodontal disease. This finding was consistent with results of other studies [15, 19, 20, 28]. It is important to mention that these studies were designed to compare periodontal disease between patients with MetS and patients without MetS, but not in patients who had diabetes and MetS. In this study, the effect of diabetes on periodontal disease was the principal factor to which the effect of other components was added, while the other studies did not take into consideration the well established relationship between diabetes and periodontal disease.
In our study, obesity was significantly associated with higher extent and severity of periodontal disease. This finding was consistent with the findings of another study in Jordan by Khader et al. (2009) [29]. Low HDL level was strongly associated with increased extent and severity of periodontal disease, while elevated TG levels were associated with significant increase in average CAL (severity) and percent of teeth with deepest CAL ≥ 3, ≥ 4 mm (extent). These findings are in agreement with the study conducted by Fentoğlu et al. (2009) [30]. However, Saxlin et al. (2008) [31] found no association between level of serum lipids and periodontal disease in normal-weight subjects, while obese subjects with high TG levels, and/or low HDL levels could be at high risk of periodontal disease.
Diabetic patients who had MetS had significantly higher prevalence of periodontal disease than those without MetS. This finding confirmed the results of Li et al. (2009) [15] and Kushiyama et al. (2009) [20]. In this study the prevalence of periodontitis in patients with diabetes was significantly increased as the number of MetS components increased. This was similar to other studies; Kushyiama et al. (2009) [20] concluded that subjects with three, four or five components of MetS exhibited a significantly higher prevalence of periodontal disease and Li et al. (2009) [15] found that prevalence of periodontal disease was less in subjects bearing fewer than two of metabolic components. Also, Hasegawa et al. (2004) [32] observed that Japanese urban women who had three or more components had a higher prevalence of periodontal disease than those who had less than two components.
In this study only low HDL level was significantly associated with increased odds of having periodontal disease in the multivariate analysis. Alike, Shimazaki et al. (2007) [28] reported that of the five components of MetS, low HDL level had the highest odds ratio and was statistically significant for a greater PPD and CAL. Similarly, Nibali et al. (2007) [33] reported that periodontitis exhibited a significant association with low HDL, high LDL, and elevated fasting blood sugar.
In conclusion, patients with MetS displayed more severe and extensive periodontitis. Having other MetS components additional to diabetes increased the odds of having periodontitis. Given the study design we used, our findings reflect the cumulative and additive effects of metabolic abnormalities on the risk of periodontal disease. Longitudinal and interventional studies are needed to confirm the study findings.
Source of funding statement
This study was partially supported by the University of Science and Technology Research Fund.
Footnotes
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RA main researcher, supervise data collection, and dental examination writing manuscript. YK data analyses, editted the manuscript. ZH data collection, examination, thesis writing. FA writing results, manuscript editting. All authors read and approved the final manuscript.
Contributor Information
Rola Alhabashneh, Email: rolaperio@yahoo.com.
Yousef Khader, Email: yousef.K@excite.com.
Zaid herra, Email: zaidherra@hotmail.com.
Farah Assad, Email: farahasaad83@gmail.com.
References
- 1.Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415–28. doi: 10.1016/S0140-6736(05)66378-7. [DOI] [PubMed] [Google Scholar]
- 2.Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert Opin Pharmacother. 2011;12(12):1887–900. doi: 10.1517/14656566.2011.585462. [DOI] [PubMed] [Google Scholar]
- 3.Beltrán Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol. 2013;62(8):697–703. doi: 10.1016/j.jacc.2013.05.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ. 2011;183(15):E1127–34. doi: 10.1503/cmaj.110070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: An urban–rural comparison. Diabetes Care. 2001;24(2):275–9. doi: 10.2337/diacare.24.2.275. [DOI] [PubMed] [Google Scholar]
- 6.Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003;26(6):1781–5. doi: 10.2337/diacare.26.6.1781. [DOI] [PubMed] [Google Scholar]
- 7.Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH. The prevalence of the metabolic syndrome among Arab Americans. Diabetes Care. 2004;27(1):234–8. doi: 10.2337/diacare.27.1.234. [DOI] [PubMed] [Google Scholar]
- 8.Onat A, Ceyhan K, Basar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels -- a prospective and cross-sectional evaluation. Atherosclerosis. 2002;165:285–9. doi: 10.1016/S0021-9150(02)00236-8. [DOI] [PubMed] [Google Scholar]
- 9.Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77:251–7. doi: 10.1016/j.diabres.2006.12.001. [DOI] [PubMed] [Google Scholar]
- 10.Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complicat. 2007;21(4):214–9. doi: 10.1016/j.jdiacomp.2005.11.003. [DOI] [PubMed] [Google Scholar]
- 11.Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066–76. doi: 10.1001/archinte.164.10.1066. [DOI] [PubMed] [Google Scholar]
- 12.Page RC, Kornman KS. The pathogenesis of human periodontitis. Periodontol. 2000;14:9–11. doi: 10.1111/j.1600-0757.1997.tb00189.x. [DOI] [PubMed] [Google Scholar]
- 13.Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbial Rev. 2001;14(4):727–52. doi: 10.1128/CMR.14.4.727-752.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Eke PI, Dye BA, Wei L, Thornton-Evans GO. Prevalence of periodontitis in adults in the United States: 2009 and 2010. Dent Res J. 2012;91(10):914–20. doi: 10.1177/0022034512457373. [DOI] [PubMed] [Google Scholar]
- 15.Li P, He L, Sha Y, Luan Q. Relationship of metabolic syndrome to chronic periodontitis. J Periodontol. 2009;80(4):541–9. doi: 10.1902/jop.2009.080387. [DOI] [PubMed] [Google Scholar]
- 16.Morita T, Yamazaki Y, Mita A, Takada K, Seto M, Nishinoue N, Sasaki Y, Motohashi M, Maeno M. A cohort study on the association between periodontal disease and the development of metabolic syndrome. J Periodontol. 2010;81(4):512–9. doi: 10.1902/jop.2010.090594. [DOI] [PubMed] [Google Scholar]
- 17.Abreu LMG, Lopes FF, Pereira AFV, Pereira ALA, Alves CMC. The interface between metabolic syndrome and periodontal disease. RSBO. 2012;9(4):434–41. [Google Scholar]
- 18.Gurav AN. The association of periodontitis and metabolic syndrome. Dent Res J (Isfahan) 2014;11(1):1–10. [PMC free article] [PubMed] [Google Scholar]
- 19.Khader Y, Khassawneh B, Obeidat B, Hammad M, El-Salem K, Bawadi H, Al-akour N. Periodontal status of patients with metabolic syndrome compared to those without metabolic syndrome. J Periodontol. 2008;79(11):2048–53. doi: 10.1902/jop.2008.080022. [DOI] [PubMed] [Google Scholar]
- 20.Kushiyama M, Shimazaki Y, Yamashita Y. Relationship between metabolic syndrome and periodontal disease in Japanese adults. J Periodontol. 2009;80(10):1610–5. doi: 10.1902/jop.2009.090218. [DOI] [PubMed] [Google Scholar]
- 21.Benquiqui C, Bongrad V, Ruidavets JB, Chamontin B, Sixous M,F, Errieres J, Amar J. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol. 2010;37(7):601–8. doi: 10.1111/j.1600-051X.2010.01571.x. [DOI] [PubMed] [Google Scholar]
- 22.Nibali L, Tatarakis N, Needleman I, Tu YK, D‘Aiuto F, Rizzo M, Donos N. Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2013;98(3):913–20. doi: 10.1210/jc.2012-3552. [DOI] [PubMed] [Google Scholar]
- 23.Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. JDent Res. 2005;84(12):1154–9. doi: 10.1177/154405910508401212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Iacopino AM, Cutler CW. Path physiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol. 2000;71(8):1375–84. doi: 10.1902/jop.2000.71.8.1375. [DOI] [PubMed] [Google Scholar]
- 25.Alberti KG, Zimmet P, Shaw J. IDF Epidemiology task force consensus group. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366:1059–62. doi: 10.1016/S0140-6736(05)67402-8. [DOI] [PubMed] [Google Scholar]
- 26.Silness J, Loe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–35. doi: 10.3109/00016356408993968. [DOI] [PubMed] [Google Scholar]
- 27.Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988–1991: Prevalence, extent, and demographic variation. J Dent Res. 1996;75:672–83. doi: 10.1177/002203459607502S07. [DOI] [PubMed] [Google Scholar]
- 28.Shimazaki Y, Saito T, Yonemoto K, Kiyohara Y, Iida M, Yamashita Y. Relationship of metabolic syndrome to periodontal disease in Japanese women: the Hisayama Study. J Dent Res. 2007;86(3):271–5. doi: 10.1177/154405910708600314. [DOI] [PubMed] [Google Scholar]
- 29.Khader YS, Bawadi HA, Haroun TF, Alomari M, Tayyem RF. The Association between periodontal disease and obesity among adults in Jordan. J Clin Periodontol. 2009;36(1):18–24. doi: 10.1111/j.1600-051X.2008.01345.x. [DOI] [PubMed] [Google Scholar]
- 30.Fentoğlu O, Oz G, Taşdelen P, Uskun E, Aykaç Y, Bozkurt FY. Periodontal status in subjects with hyperlipidemia. J Periodontol. 2009;80(2):267–73. doi: 10.1902/jop.2009.080104. [DOI] [PubMed] [Google Scholar]
- 31.Saxlin T, Suominen-Taipale L, Kattainen A, Marniemi J, Knuuttila M, Ylostalo P. Association between serum lipid levels and periodontal infection. J Clin Periodonto. 2008;35(12):1040–7. doi: 10.1111/j.1600-051X.2008.01331.x. [DOI] [PubMed] [Google Scholar]
- 32.Hasegawa T, Watase H. Multiple risk factors of periodontal disease: A study of 9260 Japanese nonsmokers. Geriatr Gerontol Int. 2004;4(1):37–43. doi: 10.1111/j.1447-0594.2003.00116.x. [DOI] [Google Scholar]
- 33.Nibali L, D’Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case–control study. J Clin Periodontol. 2007;34(11):931–7. doi: 10.1111/j.1600-051X.2007.01133.x. [DOI] [PubMed] [Google Scholar]